Rheumatoid arthritis: A review and suggested dental care considerations

Journal of the American Dental Association

Volumn 130, Issue 5, 1999, Pages 689-698

  Treister, Nathaniel ^a   Glick, Michael ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT;

DENTAL CARE; HUMAN; METHODOLOGY; MOUTH DISEASE; PATHOPHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DENTAL CARE FOR CHRONICALLY ILL; HUMANS; MOUTH DISEASES;

EID: 0033129404     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.1999.0279     Document Type: Article

References (57)

1. Short CL. The antiquity of rheumatoid arthritis. Arthritis Rheum 1974;17:193-205.
2. Kushner I, Dawson NV. Aggressive therapy does not substantially alter the long-term course of rheumatoid arthritis: so what else is new? Rheum Dis Clin North Am 1993;19:163-72.
3. Centers for Disease Control and Prevention. Prevalence of disabilities and associated health conditions - United States, 1991-1992. MMWR 1994;43:730-1, 737-9.
4. Yelin E, Callahan LF. The economic cost and social and psychological impact of muscuoskeletal conditions. Arthritis Rheum 1995;38:1351-62.
5. Centers for Disease Control and Prevention. Prevalence and impact of chronic oint symptoms - seven states, 1996. MMWR 1998;47:345-51.
6. Harris ED Jr. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
7. Lipsky PE. Rheumatoid arthritis. In: Wilson JD, Braunwald E, Isselbacher KJ, et al., eds. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill; 1998:1880-8.
8. Myllykangas-Luosujarvi RA, Aho K, Isomaki HA. Mortality in rheumatoid arthritis. Semin Arthritis Rheum 1995;25:193-202.
9. Pincus T, Brooks RH, Callahan LF. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 1994;120:26-34.
10. van Leeuwen MA, Westra J, Limburg PC, van Riel PL, van Rijswijk MH. Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid. Ann Rheum Dis 1995;54:33-8.
11. Lorenzo JA. The role of cytokines in the regulation of local bone resorption. Crit Rev Immunol 1991;11:195-213.
12. Dinarello CA. Biology of interleukin-1. FASEB J 1988;2:108-15.
13. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM. Synergistic interactions between interleukin-1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 1987;138:1464-8.
14. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographie damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 1989;16:585-91.
15. van der Heijde D, van Leeuwen MA, van Riel P, van de Putte L. Radiographic progression of radiographs on hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 1995;22:1792-6.
16. Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis? Rheum Dis Clin North Am 1993;19:123-51.
17. Pope R. Rheumatoid arthritis: pathogenesis and early recognition. Am J Med 1996;100(2A):3S-9S.
18. Yelin E, Henke C, Epstein W. The work dynamics of the person with rheumatoid arthritis. Arthritis Rheum 1987;30:507-12.
19. Gridley G, Klippel JH, Hoover RN, Fraumeni JF. Incidence of cancer among men with the Felty syndrome. Ann Intern Med 1994;120:35-9.
20. Rosenstein ED, Kramer N. Felty's and pseudo-Felly's syndromes. Semin Arthritis Rheum 1991;21:129-42.
21. Fox RI. Pathogenesis and treatment of Sjögren's syndrome. Curr Opin Rheumatol 1997;9:393-9.
22. Dugowson CE, Nelson JL, Koepsell TD. Evaluation of the 1987 revised criteria for rheumatoid arthritis in a cohort of newly diagnosed female patients. Arthritis Rheum 1990;33:1042-6.
23. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Montagna GL, Tirri R, Baruffo A, Preti B, Viaggi S. Clinical pattern of pain in rheumatoid arthritis. Clin Exp Rheumatol 1997;15:481-5.
25. Schiff M. Emerging treatments for rheumatoid arthritis. Am J Med 1997;102(suppl 1A):11S-15S.
26. Blackburn WD. Management of osteoarthritis and rheumatoid arthritis: prospects and possibilities. Am J Med 1996;100(suppl 2A):24S-30S.
27. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996:39:713-22.
28. Pincus T. The paradox of effective therapies but poor long term outcome in rheumatoid arthritis. Semin Arthritis Rheum 1992;21(suppl 3):2-15.
29. Iannuzzi L, Dawson N, Zein N. Does drug therapy slow radiographic deterioration in rheumatoid arthritis? N Engl J Med 1983;309:1023-8.
30. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 1996;39:723-31.
31. Kremer JM. The changing face of therapy for rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:845-52.
32. Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind placebo-controlled trial. Ann Intern Med 1994;121:833-41.
33. Weinblatt ME, Kaplan H, Germain BF, et al. Methotrexate in rheumatoid arthritis: a five-year prospective multicenter study. Arthritis Rheum 1994;37:1492-8.
34. Wolfe R, Hawley DJ, Cathey MA. Termination of slow-acting antirheumatic therapy in rheumatoid arthritis: a 14 year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990;17:994-1002.
35. Felson DT, Anderson JJ, Meenan RF. The efficacy and toxicity of combination therapy in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 1994;37:1484-91.
36. Henderson B. Therapeutic modification of cytokines. Ann Rheum Dis 1995;54:519-23.
37. Iacopino AM, Wathen WF. Craniomandibular disorders in the geriatric patient. J Orofac Pain 1993;7:38-52.
38. Kreutziger KL, Mahan PL. Temporomandibular degenerative joint disease I: Anatomy, pathophysiology, and clinical desciption. Oral Surg Oral Med Oral Pathol 1975;40:165-9.
39. Goupille P, Fouquet B, Goga D, Cotty P, Valat J. The temporomandibular joint in rheumatoid arthritis: correlations between clinical and tomographic features. J Dent 1993;21:141-6.
40. Redlund-Johnell L. Upper airway obstruction in patients with rheumatoid arthritis and temporomandibular joint destruction. Scand Rheumatol 1988;17:273-9.
41. Kaber UR, Gleissner C, Dehne F, Michel A, Willershausen-Zonnchen B, Bolten WW. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 1997;40:2248-51.
42. Tolo K, Jorkjend L. Serum antibodies and loss of periodontal bone in patients with rheumatoid arthritis. J Clin Periodontol 1990;17:288-91.
43. Snyderman R, McCarty GA. Analogous mechanism of tissue destruction in rheumatoid arthritis and periodontal research. In: Genco RJ, Mergenhagen SE, eds. Host-parasite interaction in periodontal disease. Washington, D.C.: American Society for Microbiology; 1982:354-62.
44. Yavuzyilmaz E, Yamalik N, Calguner M, Ersoy F, Baykara M, Yeniay I. Clinical and immunological characteristics of patients with rheumatoid arthritis and periodontal disease. J Nihon Univ Sch Dent 1992;34:89-95.
45. Howell HT. Blocking periodontal disease progression with anti-inflammatory agents. J Periodontol 1993;64:828-33.
46. Russel SL, Reisine S. Investigation of xerostomia in patients with rheumatoid arthritis. JADA 1998;129:733-9.
47. Newbrun E. Current treatment modalities of oral problems of patients with Sjögren's syndrome: caries prevention. Adv Dent Res 1996;10:29-34.
48. Atkinson J, Fox P. Sjögren's syndrome: oral and dental considerations. JADA 1993; 124:74-86.
49. Atkinson J, Wu A. Salivary gland dysfunction: causes, symptoms, treatment. JADA 1994;125:409-16.
50. Lehmann T, Day RO, Brooks PM. Toxicity of antirheumatic drugs. Med J Aust 1997;166:378-83.
51. Bannwarth B, Labat L, Monde Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis: an update. Drugs 1994;47:25-50.
52. Glick M. Glucocorticosteroid replacement therapy: a literature review and suggested replacement therapy. Oral Surg Oral Med Oral Pathol 1989;67:614-20.
53. American Dental Association, American Academy of Orthopaedic Surgeons. Antibiotic prophylaxis for dental patients with total joint replacements. JADA 1997;128:1004-8.
54. Tegelberg A, Kopp S. A 3-year follow-up of temporomandibular disorders in rheumatoid arthritis and ankylosing spondylitis. Acta Odontol Scand 1996;54:14-8.
55. Fox P, Brennan M, Pillemer S, Radfar L, Yamano S, Baum B. Sjögren's syndrome: a model for dental care in the 21st century. JADA 1998;129:719-28.
56. Risheim H, Kjoerheim V, Arneberg P. Improvement of oral hygiene in patients with rheumatoid arthritis. Scand J Dent Res 1992; 100:172-5.
57. Dunn EC, Small RE. Leflunomide: an immunomodulatory agent for rheumatoid arthritis. Formulary 1999;34:21-31.